Drugs / doxorubicin pegylated liposomal
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02759588 | May 2016 → Dec 2021 | fallopian tube cancer, ovarian cancer, peritoneal carcinomatosis | Genelux GmbH | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | doxorubicin pegylated liposomal | “Carboplatin + choice of non-platinum chemotherapy drug: taxane, paclitaxel, nab-paclitaxel, gemcitabine or doxorubicin pegylated liposomal with or without bevacizumab.” NCT02759588 ↗ |